| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |